JY
LFCR icon

Jeff Yass’s Lifecore Biomedical LFCR Stock Holding History

Jeff Yass’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Sell
20,700
-2,300
-10% -$11.6K ﹤0.01% 12441
2026
Q1 		$85.6K Buy
23,000
+12,000
+109% +$82.9K ﹤0.01% 12433
2025
Q4 		$90K Sell
11,000
-9,700
-47% -$71.8K ﹤0.01% 11511
2025
Q3 		$152K Buy
20,700
+8,800
+74% +$66.6K ﹤0.01% 11264
2025
Q2 		$96.6K Buy
+11,900
New +$80.2K ﹤0.01% 11818
2025
Q1 		– Sell
-11,400
Closed -$84.7K – 13035
2024
Q4 		$84.7K Sell
11,400
-2,700
-19% -$17.2K ﹤0.01% 11440
2024
Q3 		$69.5K Sell
14,100
-13,900
-50% -$72.6K ﹤0.01% 11242
2024
Q2 		$144K Sell
28,000
-38,100
-58% -$226K ﹤0.01% 10735
2024
Q1 		$351K Sell
66,100
-6,000
-8% -$42.9K ﹤0.01% 9340
2023
Q4 		$446K Sell
72,100
-90,200
-56% -$626K ﹤0.01% 8952
2023
Q3 		$1.23M Sell
162,300
-17,500
-10% -$160K ﹤0.01% 6177
2023
Q2 		$1.74M Buy
179,800
+159,900
+804% +$977K ﹤0.01% 5436
2023
Q1 		$75.2K Sell
19,900
-8,100
-29% -$45.2K ﹤0.01% 11486
2022
Q4 		$181K Buy
+28,000
New +$231K ﹤0.01% 10268
2014
Q3 		– Sell
-22,000
Closed -$275K – 9702
2014
Q2 		$275K Buy
22,000
+9,100
+71% +$107K ﹤0.01% 8528
2014
Q1 		$144K Buy
12,900
+2,000
+18% +$21.9K ﹤0.01% 8433
2013
Q4 		$132K Sell
10,900
-21,400
-66% -$256K ﹤0.01% 8530
2013
Q3 		$394K Buy
+32,300
New +$451K ﹤0.01% 6786

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Jeff Yass's LFCR Position: Q2 2026 in Review

Jeff Yass sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 40,789 shares — an estimated $205K sold.

Jeff Yass first reported a position in LFCR in Q3 2013 and held it in 25 quarters. The position peaked at $3.16M in Q2 2023. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Jeff Yass reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 40,789 Lifecore Biomedical shares in Q2 2026, an estimated $205K.
  • Jeff Yass first reported a position in Lifecore Biomedical in Q3 2013 and held it in 25 quarters.
  • Jeff Yass's Lifecore Biomedical position peaked at $3.16M in Q2 2023.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.